logo
Mangalam Global Enterprise Limited (MGEL) Expands Consumer Health and Wellness Portfolio with Launch of 31 New SKUs

Mangalam Global Enterprise Limited (MGEL) Expands Consumer Health and Wellness Portfolio with Launch of 31 New SKUs

VMPL
Ahmedabad (Gujarat) [India], May 28: Mangalam Global Enterprise Limited (MGEL), a part of the Mangalam Group that has carved a niche as an agri-products entity, has launched 31 new Stock Keeping Units (SKUs) in the Business-to-Consumer (B2C) nutraceuticals pace. This strategic expansion marks a significant step in strengthening the company's presence in the health and wellness sector. The diversified range of nutritional supplements and cold-pressed oils provide users with nutrients that can address the deficiencies prevalent in modern diets and lifestyles.
The newly launched SKUs include:
Nutraceutical Capsules:
* Vegan Omega 3 6 9 Capsules - 2 SKUs (Blister & Jar)
* Evening Primrose Oil Soft Vegan Capsules - 2 SKUs (Blister & Jar)
* Castor Oil Soft Vegan Capsules - 2 SKUs (Blister & Jar)
* Garlic Oil Soft Vegan Capsules - 2 SKUs (Blister & Jar)
* Immunity Booster Soft Vegan Capsules - 2 SKUs (Blister & Jar)
Cold Pressed Oils:
* Yellow Mustard Oil - 5 SKUs (60ml, 100ml, 250ml, 500ml, 1000ml)
* Extra Virgin Coconut Oil - 5 SKUs (60ml, 100ml, 250ml, 500ml, 1000ml)
* Black Sesame Oil - 5 SKUs (60ml, 100ml, 250ml, 500ml, 1000ml)
* Pistachio Oil - 2 SKUs (60ml & 100ml)
* Almond Oil - 2 SKUs (60ml & 100ml)
* Walnut Oil - 2 SKUs (60ml & 100ml)
These products are designed to cater to the evolving health-conscious preferences of modern consumers, with a special emphasis on vegan formulations and naturally extracted oils.
Commenting on the launch, a company spokesperson said, "This expansion is aligned with our vision to offer high-quality, plant-based wellness solutions that support healthier lifestyles. With this new range, we aim to deliver trusted nutrition and purity directly to consumers."
The company continues to explore opportunities in the natural and organic wellness domain, reinforcing its commitment to product innovation, sustainability, and customer well-being.
COMPANY PROFILE
Mangalam Global Enterprises Limited (MGEL) is a member of the esteemed Mangalam Group that has consistently built its reputation on quality, innovation, and trust. Operating since 1942 and headquartered in Ahmedabad, the Group is a reputed manufacturer and distributor of castor oil, mustard oil, soyabean oil and their derivatives, along with wheat, rice and ginning cotton.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Nuvama initiates coverage with a 'BUY' rating on AGI Infra (AGIIL) with a target price of Rs 1448
Nuvama initiates coverage with a 'BUY' rating on AGI Infra (AGIIL) with a target price of Rs 1448

Business Standard

timea day ago

  • Business Standard

Nuvama initiates coverage with a 'BUY' rating on AGI Infra (AGIIL) with a target price of Rs 1448

VMPL New Delhi [India], July 26: Nuvama initiates coverage with a 'BUY' rating and a TP of INR1,448, valuing the stock at 1x FY26E NAV. AGI Infra (AGIIL) is among the few reputed real estate players in Punjab, with a dominant presence in Jalandhar, aided by a strong track record of well-received, high-quality projects. Operating in a market with limited branded competition, it has established a strong position and is strategically expanding into high-demand micro-markets across Punjab. With a robust development pipeline and a sizable, well-located land bank, it is well-positioned to capitalise on Punjab's growing housing demand. Our confidence in its long-term growth story is aided by a structurally buoyant home market. Report link: Key growth Drivers are highlighted below: CAGR of 13% over FY26-30E on the back of a strong launch pipeline of ~INR5,120cr (9.8msf) and ongoing inventory of ~INR1,280 (4.98msf); I. Strong demand for its product and further price realisation; II. In-house construction using its team of experts, coupled with the use of Mivan technology, which gives it an edge in terms of faster execution, on-time delivery, and boosts margin; III. Favourable dynamics in Punjab with lower inventory and limited supply by branded players; IV. Net cash surplus of INR2,060cr over FY26-32E (sans its land bank) led by pre-sales growth; V. With a large land parcel spread across diverse locations, where demand is high, it is ready for the future. We expect a net cash surplus of INR1,506cr and a healthier Balance Sheet led by strong collections and internal accruals (net D/E ratio to improve to -0.1x in FY27E from 0.2x as of March). It has ten/four ongoing/upcoming projects, with an inventory/saleable area of 4.98msf/9.8msf (GDV of ~INR1,280cr/~INR5,120cr). Well-diversified land reserves of ~12.2msf will be used for future development. We expect GDV of ~INR1,280/~INR5,400cr ongoing inventory/upcoming to be liquidated by FY30 and envisage a cash surplus of ~INR2,060cr from ongoing and upcoming projects. We see project additions once it launches most of its existing projects. We value AGIIL on its FY26E NAV considering its land reserves and ability to add projects aggressively in its existing micro-market given its brand value and improved Balance Sheet. Organised real estate players gain an edge in underserved Punjab micro-markets Its more than two decades of experience helps it stand out among Punjab's few organised players. Jalandhar and Ludhiana are among the fastest-growing realty markets in the region, with strong traction seen in recent years. We expect continued demand and price appreciation given: i) its luxury positioning, and ii) the presence of an affluent client base. Limited supply from organised players, better infrastructure, and rising aspirations are driving demand for branded residential projects. Proven execution and strategic Tier II presence backed by a diversified portfolio AGIIL's expertise lies in residential development, with a portfolio evenly balanced between luxury and affordable housing. This ensures access to a diversified client base and resilience across market cycles. It has delivered ~9msf across 10 successful projects in Jalandhar. It is expanding in key high-growth micro-markets in Tier II cities where demand is robust. Leveraging Mivan technology and in-house execution, it is ensuring faster project execution, greater durability, and reduced labour and overhead costs. With a sizeable land bank in Tier II cities and a proven execution track record, it is best placed to sustain margin and capitalise on rising demand for branded and quality housing across Punjab. Ongoing and upcoming projects total ~14.8msf; launches seen till FY30 It has significantly scaled up given: i) the favourable market dynamics, ii) timely delivery of premium projects, and iii) strong demand for completed projects, leading to healthy collections and efficient capital recycling via internal accruals. It has 10 ongoing projects (eight residential and a commercial and plot each) with an inventory of ~4.8msf. Four upcoming projects (residential/commercial: three/ one), with a saleable area/GDV of 9.8msf/~INR5,120cr, will be launched by FY30. We expect the entire ongoing inventory to get liquidated by FY28-end. Expect a cash surplus of ~INR2,060cr over FY26-32; Net debt to equity to decline -0.1x in FY27 We expect ongoing and upcoming residential projects to generate a gross/net cash flow of INR8,283cr/INR2,060cr over FY26-32. We foresee a net D/E ratio of -0.1x by FY27 from 0.5x as of FY25on healthy internal accruals. Recommend buy with TP of Rs 1,448 We recommend Buy with a target price of Rs1,448 (upside of 36%). Our Buy recommendation is drive by 1. Well located land bank 2. Experienced management 3. Strong execution 4. Strong demand 5. Healthy cash flows 6. Comfortable balance sheet 7. Attractive valuations. Expect healthy cash flows aided by: i) the development of land parcels, ii) strong brand positioning, and iii) price premium in Punjab. We discount cash flows to FY26 to arrive at a NAV of INR3,539cr with a TP of INR1,448. Maintain BUY.

Male Infertility Identified as a Growing Contributor to India's Fertility Crisis at the 6th India IVF Summit
Male Infertility Identified as a Growing Contributor to India's Fertility Crisis at the 6th India IVF Summit

Business Standard

time2 days ago

  • Business Standard

Male Infertility Identified as a Growing Contributor to India's Fertility Crisis at the 6th India IVF Summit

VMPL New Delhi [India], July 26: Marking World IVF Day, observed globally on July 25, the 6th India IVF Summit & Awards 2025, hosted by the Integrated Health & Wellbeing (IHW) Council in collaboration with the Indian Society for Assisted Reproduction (ISAR) and sustainability hour supported by the Indian Fertility Society (IFS), brought together over 150 leading voices from India's fertility landscape. While the summit explored broader access and ethical care, a central theme that sparked significant dialogue was the growing burden of male infertility in India. With the theme "Building the World's Most Inclusive IVF Ecosystem," the summit convened clinicians, researchers, embryologists, hospital leaders, legal experts, and patient advocates at Crowne Plaza, New Delhi for a day of meaningful discussions on the future of reproductive care. Among the key discussions, male infertility emerged as a pressing public health concern. According to the Indian Society of Assisted Reproduction, India has approximately 27.5 million individuals facing infertility challenges--with male factor infertility accounting for 40-50% of these cases. This growing prevalence, driven by lifestyle changes, environmental exposures, and undiagnosed medical conditions, underscores the urgent need for awareness, destigmatization, and inclusive treatment approaches. The summit was graced by medical luminaries such as Dr. Ameet Patki- President ISAR, Dr Jaideep Malhotra, Managing Director Rainbow IVF, Past President, ISAR & FOGSI, Dr Hrishikesh Pai- Founder and Medical Director, Bloom IVF Group who shared insights on evolving clinical standards, ART governance, and the ethical dimensions of reproductive technology. While sessions addressed topics such as onco-fertility, genomics, sustainability in IVF, and expanding care to rural regions, many experts agreed that male reproductive health has long been overlooked--both in public discourse and clinical care pathways. A dedicated roundtable on male infertility offered fresh perspectives on diagnosis, counseling, and the role of men in the fertility journey. Adding a significant layer to the day's discussions was the book launch of "How to Freeze Your Biological Clock" by Dr. Gunjan Gupta, Medical Director Gunjan IVF World. The book serves as a comprehensive guide for women navigating fertility planning, but also contributes to the broader dialogue on empowering individuals--both men and women--with timely, evidence-based fertility choices. The summit also introduced the Sustainability Hour, a unique platform focused on environmentally conscious fertility practices. Innovations showcased included low-hormonal stimulation protocols, AI-powered diagnostics, and holistic, patient-first approaches that account for emotional as well as medical wellbeing. In his opening remarks, Mr Kamal Narayan, CEO, IHW Council, stated, "Male infertility is no longer a silent issue, it's a shared reality for millions of families across India. With male factors contributing to around 40-50 percent of infertility cases, this is not a marginal concern, it's a national health priority. At this summit, we recognized that fertility care must evolve to reflect this truth. We can't achieve true inclusivity without addressing male reproductive health head-on. Our goal is to build an ecosystem that is medically sound, emotionally sensitive, and socially inclusive--where care is guided by science and not stigma." The evening concluded with the IVF Awards 2025, honouring over 30 leaders and institutions advancing fertility care through innovation, compassion, and excellence. This year's edition notably amplified efforts in male infertility diagnostics and education, along with regional recognitions that celebrated unsung heroes bringing fertility services to rural and underserved communities. Dr Pankaj Talwar, President,Indian Fertility Society , noted, "For too long, infertility has been viewed through a lens focused only on women, while male infertility now contributing to nearly half of all cases remains shrouded in silence. With rising cases linked to factors like stress, obesity, hormonal imbalances, lifestyle habits such as smoking and alcohol use, and even medication side effects, the issue is more complex than ever. This summit has brought much-needed attention to the male side of the equation. Addressing it openly is critical to building a truly equitable and evidence-based approach to reproductive health in India." Mrs Nikky Gupta, CEO & Co-Founder of Teamwork Communications Group, added, "India stands at a crossroads in its fertility journey. With nearly half of infertility cases involving male factors, we can no longer afford to treat this as a secondary concern. Our response must be holistic and future-ready combining early diagnostics, accessible counselling, targeted public awareness, and strong clinical protocols tailored to male reproductive health. From tackling lifestyle-related causes like obesity and substance use to addressing underlying medical conditions and stigma, male infertility must now take center stage in our national reproductive health narrative and policymaking." As India's IVF market is projected to grow fivefold by 2030--from USD 750 million in 2020 to USD 3.7 billion--the summit reinforced a deeper commitment: to not only expand fertility treatment options, but also to dismantle the stigma surrounding male infertility and restore dignity to every individual's journey to parenthood. The 6th India IVF Summit & Awards 2025, organized by IHW Council in association with ISAR and supported by IFS, is supported by associate partners Meyer Vitabiotics and BSV, session partners Gufic Biosciences and JB Pharma, fertility insurance partner SafeTree, healthcare finance partner Fibe, legal partner Trust Legal, and communication partner Teamwork Communications Group.

Shree Refrigerations Brings Defense-Grade HVAC Legacy to Markets with Upcoming IPO
Shree Refrigerations Brings Defense-Grade HVAC Legacy to Markets with Upcoming IPO

Business Standard

time2 days ago

  • Business Standard

Shree Refrigerations Brings Defense-Grade HVAC Legacy to Markets with Upcoming IPO

VMPL New Delhi [India], July 25: Shree Refrigerations Limited, India's leading defense-focussed manufacturer of advanced refrigeration and HVAC systems, has announced its upcoming Initial Public Offering (IPO), with the issue set to open on 25th July 2025 and close on 29th July 2025. The Anchor Book will open on 24th July 2025. The equity shares are proposed to be listed on BSE SME. Incorporated in 2006, Shree Refrigerations Limited has established itself as a strategic partner to the Indian defense sector. The company specializes in designing and delivering mission-critical HVAC and refrigeration systems engineered for naval platforms including submarines, built to withstand extreme maritime conditions. Its robust portfolio also includes Radar Cooling Systems, Data Center Cooling Units, Heat Exchangers, custom-built Electrical Control Panels, and Heavy Fabrication Services catering to large-scale defense manufacturing needs. The IPO comprises a Fresh Issue of 75,61,000 equity shares and an Offer for Sale (OFS) of 18,25,000 equity shares, aggregating to a total of ₹ 1,17,32,50,000. The price band per equity share is fixed at ₹119 - ₹125 and the minimum application lot size is 1,000 equity shares. The allocation under the IPO is made in accordance with SEBI regulations, with 44,55,000 (47.46%) shares reserved for Qualified Institutional Buyers (QIBs), 13,39,000 (14.27%) for Non-Institutional Investors (NIIs), and 31,22,000 (33.26%) for Retail Individual Investors (RIIs). The net proceeds from the Fresh Issue will be used to fund the working capital requirements of the company and for general corporate purposes. These funds are expected to support the company's ongoing expansion and enhance its ability to serve critical defense infrastructure projects with greater efficiency and scale. Mr. Ravalnath Gopinath Shende, Promoter and Chairman of Shree Refrigerations Limited, stated, "This IPO marks a significant milestone in our journey of engineering excellence. Over the years, we have built a reputation for delivering reliable, high-performance refrigeration and HVAC systems for mission-critical applications. As we enter this new phase, we aim to scale our operations and deepen our commitment to India's defense ecosystem by providing robust, indigenous solutions that uphold the highest standards of efficiency, durability, and national service." Led by a seasoned leadership team, including Co-founder Mrs. Rajashri Shende, Business Strategist Mrs. Devashree Nampurkar, Defense Veteran and Former Indian Navy officer Mr. Sunil Kaushik, and Capital Allocation Expert Mr. Vivek Karnavat, the company is governed by a Board of Directors comprising distinguished professionals with deep expertise across engineering, finance, and national security.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store